Bausch Historical Income Statement
| BHC Stock | USD 8.12 0.23 2.92% |
Historical analysis of Bausch Health income statement accounts such as Interest Expense of 1.4 B, Selling General Administrative of 2.4 B or Total Revenue of 9.2 B can show how well Bausch Health Companies performed in making a profits. Evaluating Bausch Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bausch Health's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Bausch Health Companies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bausch Health Companies is a good buy for the upcoming year.
Bausch |
About Bausch Income Statement Analysis
Bausch Health Companies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bausch Health shareholders. The income statement also shows Bausch investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Bausch Health Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Bausch Health Companies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Bausch Health Companies minus its cost of goods sold. It is profit before Bausch Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bausch Health Companies. It is also known as Bausch Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Bausch Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At present, Bausch Health's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 9.2 B, whereas Depreciation And Amortization is forecasted to decline to about 884.5 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.0B | 5.8B | 6.2B | 6.5B | Total Revenue | 8.4B | 8.1B | 8.8B | 9.2B |
Bausch Health income statement Correlations
Click cells to compare fundamentals
Bausch Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bausch Health income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 1.9B | 1.9B | 1.5B | 1.3B | 1.3B | 884.5M | |
| Interest Expense | 1.6B | 1.5B | 1.4B | 1.5B | 1.3B | 1.4B | |
| Selling General Administrative | 2.0B | 1.9B | 2.1B | 2.1B | 2.3B | 2.4B | |
| Total Revenue | 8.6B | 8.0B | 8.4B | 8.1B | 8.8B | 9.2B | |
| Gross Profit | 6.3B | 5.8B | 6.0B | 5.8B | 6.2B | 6.5B | |
| Other Operating Expenses | 8.7B | 6.7B | 7.2B | 6.8B | 7.8B | 8.2B | |
| Operating Income | (73M) | 676M | 1.2B | 1.4B | 963M | 1.0B | |
| Ebit | (73M) | 631.7M | 398.5M | 1.3B | 978.4M | 661.1M | |
| Ebitda | 1.8B | 2.6B | 1.9B | 2.6B | 2.2B | 1.5B | |
| Cost Of Revenue | 2.4B | 2.2B | 2.4B | 2.4B | 2.6B | 2.7B | |
| Total Operating Expenses | 6.3B | 4.5B | 4.8B | 4.4B | 5.2B | 5.5B | |
| Income Before Tax | (1.8B) | (934M) | (1.0B) | (129M) | (390M) | (409.5M) | |
| Total Other Income Expense Net | (1.8B) | (1.6B) | (1.5B) | (1.5B) | (1.4B) | (1.3B) | |
| Net Income | (1.8B) | (559M) | (937M) | (212M) | (592M) | (562.4M) | |
| Income Tax Expense | (54M) | (375M) | (87M) | 83M | 221M | 232.1M | |
| Research Development | 471M | 452M | 465M | 529M | 604M | 634.2M | |
| Net Income Applicable To Common Shares | (1.8B) | (560M) | (948M) | (225M) | (202.5M) | (212.6M) | |
| Selling And Marketing Expenses | 544M | 451M | 515M | 518M | 625M | 430.3M | |
| Net Income From Continuing Ops | (1.8B) | (559M) | (937M) | (212M) | (611M) | (641.6M) | |
| Non Recurring | 106M | 136M | 234M | 15M | 13.5M | 12.8M | |
| Non Operating Income Net Other | (22M) | (76M) | (48M) | 881M | 1.0B | 1.1B | |
| Tax Provision | (54M) | (375M) | (87M) | 83M | 221M | 232.1M | |
| Net Interest Income | (1.6B) | (1.5B) | (1.4B) | (1.5B) | (1.3B) | (1.4B) | |
| Reconciled Depreciation | 2.1B | 1.8B | 1.4B | 1.2B | 1.3B | 1.5B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (0.48) | Revenue Per Share 25.794 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0415 |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.